Bringing the fundamentals into focus…
Back to Nurix Therapeutics, Inc.
How Nurix Therapeutics, Inc. stacks up
NRIX · against 1,216 other Healthcare companies
Growth
98/ 100
Near the top of its peers.
Ranked #20 of 1,217 · scores higher than 98% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including NRIX · Click a bar to see the companies
Why growth scores 98?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, 3-year revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- Earnings per share turned from a loss to a profit. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 97% of peers. 3-year revenue growth: 117.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 99% of peers. Revenue growth: 738.8% vs peer median 6.1%
Metric by metric
Position: dot = NRIX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NRIX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 738.8% | 6.1% | 99% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 117.1% | 5.8% | 97% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around NRIX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 20 | 595M USD | 98 | 97 | |
| 20 | 804M CHF (≈$924M) | 98 | ||
| 20 | 3.8B USD | 98 | 71 | |
| 20 | 914M USD | 98 | 81 | |
| 20 | 2.7B USD | 98 | 84 | |
| 20 | 79M EUR (≈$87M) | 98 | 34 | |
| 20 | 217M AUD (≈$143M) | 98 | 43 | |
| 20 | 9.3B USD | 98 | 64 | |
| 32 | 2.6B CNY (≈$359M) | 97 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score